%PDF-1.4
%
1 0 obj
<<
/MarkInfo
<<
/Marked true
>>
/Metadata 3 0 R
/Outlines 4 0 R
/PageLayout/OneColumn
/Pages 5 0 R
/StructTreeRoot 6 0 R
/Type/Catalog
>>
endobj
2 0 obj
<<
/Author(CHMP)
/Comments(Template developed for European Medicines Agency by Fiona Lewis and Vanessa Crookes December 2009)
/Company(European Medicines Agency)
/CreationDate(D:20180321180215Z)
/Creator(Acrobat PDFMaker 11 for Word)
/DM_Author()
/DM_Authors()
/DM_Category(EPAR)
/DM_Creation_Date(12/01/2018 10:06:29)
/DM_Creator_Name(Castellani Federica)
/DM_DocRefId(EMA/830788/2017)
/DM_Keywords()
/DM_Language()
/DM_Modifer_Name(Castellani Federica)
/DM_Modified_Date(12/01/2018 10:06:29)
/DM_Modifier_Name(Castellani Federica)
/DM_Modify_Date(12/01/2018 10:06:29)
/DM_Name(Tarceva EPAR summary update II-51)
/DM_Owner(Gadd Christopher)
/DM_Path(/01. Evaluation of Medicines/H-C/S-U/Tarceva-000618/05 Post Authorisation/EPAR/EPAR summary working area/06 Update for II-51)
/DM_Status()
/DM_Subject()
/DM_Title()
/DM_Type(emea_document)
/DM_Version(1.7,CURRENT)
/DM_emea_bcc()
/DM_emea_cc()
/DM_emea_doc_category(EPAR)
/DM_emea_doc_lang()
/DM_emea_doc_number(355215)
/DM_emea_doc_ref_id(EMA/830788/2017)
/DM_emea_domain(H)
/DM_emea_filing_code( )
/DM_emea_from()
/DM_emea_internal_label(EMA)
/DM_emea_legal_date(nulldate)
/DM_emea_meeting_action()
/DM_emea_meeting_flags()
/DM_emea_meeting_hyperlink()
/DM_emea_meeting_ref()
/DM_emea_meeting_status()
/DM_emea_meeting_title()
/DM_emea_message_subject()
/DM_emea_module()
/DM_emea_par_dist()
/DM_emea_procedure(C)
/DM_emea_procedure_number()
/DM_emea_procedure_ref(EMEA/H/C/000618)
/DM_emea_procedure_type()
/DM_emea_product_number(000618)
/DM_emea_product_substance(Tarceva)
/DM_emea_received_date(nulldate)
/DM_emea_resp_body()
/DM_emea_revision_label()
/DM_emea_sent_date(nulldate)
/DM_emea_to()
/DM_emea_year(2010)
/Keywords(Tarceva, INN-erlotinib)
/ModDate(D:20180702150824+08'00')
/Producer(PDFsharp 1.32.2608-g \(www.pdfsharp.net\) \(Original: Adobe PDF Library 11.0\))
/SourceModified(D:20180321175256)
/Subject(EPAR)
/Title(Tarceva, INN-erlotinib)
>>
endobj
3 0 obj
<<
/Subtype/XML
/Type/Metadata
/Length 7293
>>
stream
2018-03-23T11:15:26Z
2018-03-21T18:02:15Z
2018-03-23T11:15:26Z
Acrobat PDFMaker 11 for Word
uuid:b2c3709b-cae2-42c9-a81b-664b8806216d
uuid:04b1c270-9ec3-4cc8-afaa-1713d617aa28
3
application/pdf
Tarceva, INN-erlotinib
EPAR
CHMP
Tarceva
INN-erlotinib
Adobe PDF Library 11.0
Tarceva, INN-erlotinib
D:20180321175256
European Medicines Agency
Template developed for European Medicines Agency by Fiona Lewis and Vanessa Crookes December 2009
EPAR
12/01/2018 10:06:29
Castellani Federica
EMA/830788/2017
EPAR
355215
EMA/830788/2017
H
EMA
nulldate
C
EMEA/H/C/000618
000618
Tarceva
nulldate
nulldate
2010
Castellani Federica
12/01/2018 10:06:29
Castellani Federica
12/01/2018 10:06:29
Tarceva EPAR summary update II-51
Gadd Christopher
/01. Evaluation of Medicines/H-C/S-U/Tarceva-000618/05 Post Authorisation/EPAR/EPAR summary working area/06 Update for II-51
emea_document
1.7,CURRENT
EPAR-EMA/355215/2010
endstream
endobj
4 0 obj
<<
/Count 10
/First 7 0 R
/Last 8 0 R
/Type/Outlines
>>
endobj
5 0 obj
<<
/Count 3
/Kids[9 0 R 10 0 R 11 0 R]
/Type/Pages
>>
endobj
6 0 obj
<<
/K 12 0 R
/ParentTree 13 0 R
/ParentTreeNextKey 5
/RoleMap 14 0 R
/Type/StructTreeRoot
>>
endobj
7 0 obj
<<
/A 15 0 R
/Next 16 0 R
/Parent 4 0 R
/Title(What is Tarceva and what is it used for?)
>>
endobj
8 0 obj
<<
/A 17 0 R
/Parent 4 0 R
/Prev 18 0 R
/Title(Other information about Tarceva)
>>
endobj
9 0 obj
<<
/Contents[19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 181 0 R]
/CropBox[0 0 595.32 841.92]
/Group 27 0 R
/MediaBox[0 0 595.32 841.92]
/Parent 5 0 R
/Resources
<<
/ColorSpace
<<
/CS0 28 0 R
/CS1 29 0 R
/CS2 30 0 R
/CS3 31 0 R
>>
/ExtGState
<<
/GS0 32 0 R
/GS1 182 0 R
>>
/Font
<<
/C2_0 33 0 R
/C2_1 34 0 R
/TT0 35 0 R
/TT1 36 0 R
/TT2 37 0 R
>>
/XObject
<<
/Im0 38 0 R
/Im1 39 0 R
>>
>>
/Rotate 0
/StructParents 0
/Tabs/S
/Type/Page
>>
endobj
10 0 obj
<<
/Contents[40 0 R 183 0 R]
/CropBox[0 0 595.32 841.92]
/MediaBox[0 0 595.32 841.92]
/Parent 5 0 R
/Resources
<<
/ColorSpace
<<
/CS0 29 0 R
/CS1 30 0 R
>>
/Font
<<
/C2_0 34 0 R
/TT0 35 0 R
/TT1 36 0 R
/TT2 37 0 R
>>
/ExtGState
<<
/GS0 182 0 R
>>
>>
/Rotate 0
/StructParents 1
/Tabs/S
/Type/Page
/Group
<<
/CS/DeviceRGB
/S/Transparency
/I false
/K false
>>
>>
endobj
11 0 obj
<<
/Annots 41 0 R
/Contents[42 0 R 184 0 R]
/CropBox[0 0 595.32 841.92]
/MediaBox[0 0 595.32 841.92]
/Parent 5 0 R
/Resources
<<
/ColorSpace
<<
/CS0 29 0 R
/CS1 30 0 R
>>
/Font
<<
/TT0 35 0 R
/TT1 36 0 R
>>
/ExtGState
<<
/GS0 182 0 R
>>
>>
/Rotate 0
/StructParents 2
/Tabs/S
/Type/Page
/Group
<<
/CS/DeviceRGB
/S/Transparency
/I false
/K false
>>
>>
endobj
12 0 obj
<<
/K[43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R 75 0 R]
/P 6 0 R
/S/Sect
>>
endobj
13 0 obj
<<
/Nums[0 76 0 R 1 77 0 R 2 78 0 R 3 79 0 R 4 79 0 R]
>>
endobj
14 0 obj
<<
/Annotation/Span
/Artifact/P
/Bibliography/BibEntry
/Body#20text#20#28Agency#29/P
/Chart/Figure
/Diagram/Figure
/Doc#20category#20heading#20#28Agency#29/P
/Doc#20subtitle#20#28Agency#29/P
/Doc#20title#20#28Agency#29/P
/Drafting#20Notes#20#28Agency#29/Span
/DropCap/Figure
/Endnote/Note
/Footnote/Note
/Hyperlink/Span
/InlineShape/Figure
/No-num#20heading#203#20#28Agency#29/H3
/No-num#20heading#205#20#28Agency#29/H5
/Outline/Span
/Ref.#20#28Agency#29/P
/Strikeout/Span
/Subscript/Span
/Superscript/Span
/TextBox/Art
/Underline/Span
>>
endobj
15 0 obj
<<
/D[9 0 R/XYZ 60 435 0]
/S/GoTo
>>
endobj
16 0 obj
<<
/A 80 0 R
/Next 81 0 R
/Parent 4 0 R
/Prev 7 0 R
/Title(How is Tarceva used?)
>>
endobj
17 0 obj
<<
/D[11 0 R/XYZ 60 348 0]
/S/GoTo
>>
endobj
18 0 obj
<<
/A 82 0 R
/Next 8 0 R
/Parent 4 0 R
/Prev 83 0 R
/Title(What measures are being taken to ensure the safe and effective use of Tarceva?)
>>
endobj
19 0 obj
<<
/Filter/FlateDecode
/Length 728
>>
stream
xVN@}ẈW, H@XC4HEbFm3Em
Eq̙9ggsvv9PAێ'us`Z/\" "#d kv
bNWŸ5dYР3,ȭxw&>cDAҧ#4A 3hᤔd>:)g{(Wmj4duMLrNԭk=ORoQ}j~AӶ|AAkaV;byMy@ ,Mߨ'toD)cյdՂ.l#1_n( "BFwR-a(rE?Y%IfE`Ng77phOo2¤c%^U<ʰ,{\hV&l
i^RQs2WFB/1@o;[\/4i+V鎪\mnr,}r.< luC悞% FXv]a#hL?eJqÏ 1@S}{ 2}HDMgӴ$R;P액-C3Me5/o_u*|:_UTJr*Yp$a'?h8tRtIJ-h,̀̑~E
~/h8:_
endstream
endobj
20 0 obj
<<
/Filter/FlateDecode
/Length 669
>>
stream
xUMo0WhcBQ%a5t_hu9$ua,E]uWCd